Benjamin Edwards Inc’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Benjamin Edwards Inc's IBB Position: Q2 2026 in Review
Benjamin Edwards Inc reduced its iShares Biotechnology ETF (IBB) stake by 80% in Q2 2026, selling an estimated $2.17M and leaving 3,231 shares worth $614K. The position accounts for 0.01% of the portfolio, ranked #979.
Benjamin Edwards Inc first reported a position in IBB in Q1 2020 and has held it in 18 quarters since. The position peaked at $2.68M in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Benjamin Edwards Inc held 3,231 shares of iShares Biotechnology ETF worth $614K as of Q2 2026.
- Benjamin Edwards Inc sold 12,654 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.17M.
- iShares Biotechnology ETF made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #979 holding.
- Benjamin Edwards Inc first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 18 quarters since.
- Benjamin Edwards Inc's iShares Biotechnology ETF position peaked at $2.68M in Q1 2026.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.